Abstract

Sarcomatoid carcinoma is a rare malignant tumor that has both malignant epithelial and mesenchymal components. We describe a sarcomatoid carcinoma arising in the right renal pelvis of a 68-year-old man. The dominant component of the tumor was osteosarcomatous, but there were also focal carcinomatous areas. The sarcomatous tumor cells produced abundant osteoid matrix surrounded by osteoblastic cells. The carcinomatous tumor cells consisted of papillary urothelial carcinoma. Immunohistochemical assay showed that the sarcomatous tumor cells were positive for vimentin and negative for cytokeratin. The papillary urothelial carcinoma was positive for cytokeratin and negative for vimentin. After surgery, the patient underwent adjuvant chemotherapy. Four months later, he presented with recurrence in the right subphrenic area and metastasis in the right middle lobe of the lung.

Highlights

  • Sarcomatoid carcinoma is a rare high-grade malignant neoplasm that shows morphologic and immunohistochemical evidence of both epithelial and mesenchymal differentiation [1]

  • We report an additional case of renal pelvic sarcomatoid carcinoma showing exuberant osteosarcomatous differentiation

  • The papillary urothelial carcinoma cells were positive for cytokeratin and negative for vimentin

Read more

Summary

Introduction

Sarcomatoid carcinoma is a rare high-grade malignant neoplasm that shows morphologic and immunohistochemical evidence of both epithelial and mesenchymal differentiation [1]. This tumor can occur in various organs including the bladder, breast, larynx, esophagus, kidney and female genital tract [2,3]. The renal pelvis is an extremely rare site of origin for sarcomatoid carcinoma. To the best of our knowledge, fewer than 20 cases of sarcomatoid carcinoma of the renal pelvis have been reported [2]. We report an additional case of renal pelvic sarcomatoid carcinoma showing exuberant osteosarcomatous differentiation

Case Report
Findings
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call